Published in:
01-05-2020 | Stress Incontinence | Original Article
Urinary tract morbidity after nerve-sparing radical hysterectomy in women with cervical cancer
Authors:
Marta Novackova, Zlatko Pastor, Roman Chmel Jr, Tomas Brtnicky, Roman Chmel
Published in:
International Urogynecology Journal
|
Issue 5/2020
Login to get access
Abstract
Introduction and hypothesis
Nerve-sparing radical hysterectomy (NSRH) has been developed as a method of cervical cancer treatment to reduce surgical morbidity compared with radical abdominal hysterectomy. The aim of this study was to analyze the short- and long-term effects of NSRH on urinary tract function.
Methods
A study group of 117 patients underwent NSRH type C1 with pelvic lymphadenectomy for cervical cancer stages IB1–IB2 without adjuvant radiotherapy at our department. A total of 106 patients aged 21–74 years (mean age 44.8) were available for follow-up at 1 year after surgery. A transurethral catheter was left in place for 48 h after surgery, and the postvoid residual (PVR) volume was measured after its removal. One week before surgery and 12 months after NSRH, lower urinary tract function was evaluated by an urodynamic examination.
Results
Five days after surgery, the PVR volume was greater than 100 ml in 5 patients (4.7%) and a suprapubic catheter was inserted into these women for bladder training over the following days. Within 14 days after surgery, urination without PVR was achieved in all women who underwent surgery. Postoperatively, a slight increase in the average maximum bladder cystometric capacity was recorded from 420 to 445 ml (p value 0.009) without prolonging the voiding time. Other urodynamic parameters were not significantly different before and 12 months after NSRH.
Conclusions
In this series, NSRH preserved voiding function and bladder sensation at 1 year and did not appear to compromise oncological outcome.